Breaking News Instant updates and real-time market news.

MS

Morgan Stanley

$46.59

0.08 (0.17%)

, JPM

JPMorgan

$90.89

-0.31 (-0.34%)

07:34
07/22/17
07/22
07:34
07/22/17
07:34

Big bank profits could be lifted 30% by deregulation, Barron's says

While a major overhaul is unlikely, recent proposals by the Treasury Department to ease the regulatory burden on banks and support greater lending may lead to some changes, Andrew Bary writes in this week's edition of Barron's. Big banks, such as Morgan Stanley (MS), JPMorgan (JPM), Goldman Sachs (GS), Citigroup (C), State Street (STT), and BNY Mellon (BK), could get a cumulative earnings boost averaging 30% if a series of regulatory-relief actions take place, the report noted, citing a report issued by KBW analysts Brian Kleinhanzl and Michael Brown.Reference Link

MS

Morgan Stanley

$46.59

0.08 (0.17%)

JPM

JPMorgan

$90.89

-0.31 (-0.34%)

GS

Goldman Sachs

$220.18

-2.12 (-0.95%)

C

Citi

$66.00

-0.36 (-0.54%)

STT

State Street

$90.99

0.12 (0.13%)

BK

BNY Mellon

$53.36

-0.55 (-1.02%)

  • 25

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 01

    Aug

  • 01

    Aug

  • 12

    Oct

  • 17

    Oct

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

MS Morgan Stanley
$46.59

0.08 (0.17%)

06/28/17
FBCO
06/28/17
NO CHANGE
Target $47
FBCO
Neutral
Morgan Stanley estimates lowered at Credit Suisse
Credit Suisse analyst Susan Roth Katzke lowered her estimates for Morgan Stanley to reflect the current low volume/low volatility trading environment. She maintains a Neutral rating and $47 price target on the stock.
06/26/17
MACQ
06/26/17
NO CHANGE
Target $51
MACQ
Outperform
Macquarie says to buy Morgan Stanley at Macquarie
Morgan Stanley analyst David Konrad recommends buying Morgan Stanley today following DFAST results and recent share underperformance. The analyst believes results came in better than expected and sees additional room for buybacks of up to $5.5B from a previous estimate of $4.9B. Konrad rates shares an Outperform with a $51 price target.
06/09/17
RBCM
06/09/17
NO CHANGE
RBCM
House financial reform bill unlikely to advance in Senate, says RBC Capital
RBC Capital analyst Gerard Cassidy says that the financial regulation reform bill passed yesterday by the House would help the banking sector but probably won;t be passed by the Senate. Large publicly traded banks include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC).
06/02/17
NOMU
06/02/17
NO CHANGE
NOMU
Goldman Sachs, Morgan Stanley Q2 EPS estimates lowered at Nomura Instinet
Nomura Instinet analyst Steven Chubak cut his Q2 EPS estimate for Goldman Sachs (GS) to $3.50 from $4.04 and lowered his Q2 EPS estimate for Morgan Stanley (MS) to 77c from 86c. The consensus EPS estimates for Goldman and Morgan Stanley are $3.92 and 84c, respectively. Chubak says that Goldman has been hurt by "weaker trading and more pronounced (investment banking) declines," while Morgan Stanley is experiencing "softer" investment banking results and "more pronounced quarter-over-quarter" fixed income declines. He keeps a Neutral rating on Goldman and a Buy rating on Morgan stanley.
JPM JPMorgan
$90.89

-0.31 (-0.34%)

07/06/17
07/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Nike (NKE) initiated with an Outperform at Raymond James. 2. JPMorgan (JPM) initiated with a Neutral at Goldman Sachs. 3. At Home Group (HOME) initiated with a Buy at SunTrust. 4. Logitech (LOGI) initiated with a Buy at Citi. 5. Medtronic (MDT) initiated with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/06/17
GSCO
07/06/17
INITIATION
Target $93
GSCO
Neutral
JPMorgan initiated with a Neutral at Goldman Sachs
Goldman analyst Richard Ramsden resumed coverage on JPMorgan with a Neutral and a $93 price target saying it is a best-in-class franchise with a premium multiple.
06/29/17
FBCO
06/29/17
NO CHANGE
Target $102
FBCO
Outperform
JPMorgan price target raised to $102 after CCAR review at Credit Suisse
Factoring in a share repurchase authorization for the 2017 CCAR cycle that she notes was 15% above her forecast and carrying through a higher rate of capital return into 2018, Credit Suisse analyst Susan Roth Katzke raised her price target on JPMorgan shares to $102 from $99 after the bank received Fed approval for its CCAR plan. The analyst keeps an Outperform rating on JPMorgan.
07/11/17
BARD
07/11/17
NO CHANGE
BARD
Big bank set-up not great, would sell into extended rally, says Baird
Baird analyst David George does not see a great set-up for money-center banks heading into Q2 earnings. He said the trade looks crowded and he would be a seller into an extended rally. George said the risk/reward is less attractive following the sector's most recent rally as economic growth remains muted and the pace of NIM expansion may slow. George believes the biggest potential catalyst would be a gradual steepening of the yield curve and pick-up on loan growth.
GS Goldman Sachs
$220.18

-2.12 (-0.95%)

06/28/17
FBCO
06/28/17
NO CHANGE
Target $240
FBCO
Outperform
Goldman Sachs price target raised to $240 from $230 at Credit Suisse
Credit Suisse analyst Susan Roth Katzke lowered her 2017 estimates for Goldman Sachs to reflect the current low volume/low volatility trading environment. However, assuming capital markets growth follows macroeconomic growth and the company realizes incremental operating leverage, she increased her 2018 and 2019 estimates for Goldman. Katzke increased her price target on Goldman shares to $240 from $230 and keeps an Outperform rating on the stock.
07/19/17
KBWI
07/19/17
DOWNGRADE
KBWI
Market Perform
Goldman Sachs downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl downgraded Goldman Sachs to Market Perform from Outperform and cut his price target for the shares to $230 from $260. The analyst sees a weakening revenue outlook following the investment bank's Q2 results.
07/19/17
OPCO
07/19/17
NO CHANGE
Target $256
OPCO
Outperform
Goldman Sachs price target raised to $256 from $251 at Oppenheimer
Oppenheimer analyst Chris Kotowski raised his price target for Goldman Sachs to $256 from $251 as he still thinks there is a "reasonable probability" of a FICC rebound once long-term rates go up and thinks the market is awarding a near zero value to this. The analyst reiterates an Outperform rating on the shares.
07/19/17
07/19/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AMC Entertainment (AMC) downgraded to Equal Weight from Overweight at Barclays with analyst Kannan Venkateshwar saying he sees increased risk after China indicated over the weekend that the government has blocked banks from funding AMC's parent, Chinese real estate conglomerate Dalian Wanda. 2. Chipotle (CMG) downgraded to Market Perform from Outperform at BMO Capital and Wells Fargo. 3. Goldman Sachs (GS) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Brian Kleinhanzl saying he sees a weakening revenue outlook following the investment bank's second quarter results. 4. PayPal (PYPL) downgraded to Hold from Buy at SunTrust with analyst Andrew Jeffrey citing valuation, "long-term competitive risk, and uncertain Venmo monetization." 5. First Solar (FSLR) downgraded to Hold from Buy at Standpoint Research with analyst Ronnie Moas saying the stock is fairly valued after jumping 70% over the past three months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
C Citi
$66.00

-0.36 (-0.54%)

06/09/17
06/09/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Zynga (ZNGA) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Brian Nowak saying the company's in-game innovation, starting with Poker, is resulting in higher engagement and monetization. 2. Citi (C) upgraded to Neutral from Sell at UBS with analyst Saul Martinez saying he sees an improved risk/reward at current share levels. Global growth "looks resilient," protectionist policies have not emerged, and the path forward for structural reforms in the U.S. "is not as clear." 3. Comerica (CMA) upgraded to Outperform from Market Perform at FBR Capital. 4. Camping World (CWH) upgraded to Buy from Neutral at Goldman Sachs with analyst David Tamberrino saying he expects growth to continue despite late-cycle concerns. 5. Humana (HUM) upgraded to Buy from Hold at Argus with analyst David Toung saying he is upbeat about its growth outlook following the termination of its merger deal with Aetna (AET). This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/17
HSBC
07/11/17
INITIATION
Target $71
HSBC
Hold
Citi initiated with a Hold at HSBC
HSBC analyst Alevizos Alevizakos initiated Citi with a Hold and a $71 price target saying higher profitability and buybacks appear reflected in valuation.
07/11/17
07/11/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Blue Apron (APRN) initiated with a Sell rating and $2.00 price target at Northcoast. 2. Cheesecake Factory (CAKE) initiated with an Outperform at Wedbush. 3. Graphic Packaging (GPK) initiated with a Buy at DA Davidson. 4. Masimo (MASI) initiated with a Buy at Stifel. 5. Citi (C) initiated with a Hold at HSBC. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/17/17
FBCO
07/17/17
NO CHANGE
Target $72
FBCO
Outperform
Citi price target raised to $72 from $64 at Credit Suisse
Credit Suisse analyst Susan Roth Katzke raised her price target for Citi to $72 from $64 following a better than expected Q2. The analyst reiterates an Outperform rating on the shares.
STT State Street
$90.99

0.12 (0.13%)

06/28/17
GSCO
06/28/17
UPGRADE
Target $100
GSCO
Conviction Buy
State Street upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman analyst Alexander Blostein added State Street to the Conviction Buy List and increased its price target to $100 from $92 saying pre-tax margin targets look conservative, providing confidence in above consensus estimates. The analyst estimates fee growth grew 4%+ quarter-over-quarter in Q2 due to a favorable fee mix shift amid non-US equities outperformance and flows accelerated into the company's higher-fee ETFs.
06/05/17
UBSW
06/05/17
UPGRADE
Target $92
UBSW
Buy
State Street upgraded to Buy from Neutral at UBS
UBS analyst Brennan Hawken upgraded State Street to Buy and raised his price target for the shares to $92 from $86. The analyst believes investor concerns about increased competitive pressure has brought an attractive buying opportunity. After meeting with management, Hawken has greater confidence in the earnings outlook for the company's European business.
05/26/17
05/26/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Immunomedics (IMMU) initiated with an Outperform at Cowen. 2. Sherwin-Williams (SHW) initiated with a Hold at Jefferies. 3. State Street (STT) reinstated with a Neutral at BofA/Merrill. 4. Zoetis (ZTS) initiated with a Buy at CL King. 5. BioDelivery Sciences (BDSI) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/26/17
BOFA
05/26/17
INITIATION
Target $88
BOFA
Neutral
State Street reinstated with a Neutral at BofA/Merrill
BofA/Merrill analyst Michael Carrier reinstated coverage on State Street with a Neutral and a $88 price target citing its lower growth outlook.
BK BNY Mellon
$53.36

-0.55 (-1.02%)

05/26/17
BOFA
05/26/17
INITIATION
Target $49
BOFA
Underperform
BNY Mellon reinstated with an Underperform at BofA/Merrill
BofA/Merrill analyst Michael Carrier reinstated coverage on BNY Mellon with an Underperform and a $49 price target given low revenue growth outlook.
04/13/17
DBAB
04/13/17
NO CHANGE
DBAB
Deutsche recommends long BNY Mellon, short State Street pair trade
Ahead of earnings reports from the brokers, asset managers and exchanges, Deutsche Bank analyst Brian Bedell recommends a pair trade to go long BNY Mellon (BK) versus short State Street (STT), as he sees NY Mellon narrowly beating consensus while he expects State Street to post a slight miss and also predicts downward revisions to 2017. Bedell keeps a Buy rating on BNY Mellon and a Hold rating on State Street.
03/03/17
EVER
03/03/17
DOWNGRADE
Target $48
EVER
Underperform
BNY Mellon downgraded to Underperform from Hold at Evercore ISI
Evercore ISI changed its rating system to Outperform, In Line and Underperform. Analyst Glenn Schorr downgraded BNY Mellon saying shares will benefit less versus peers from lower taxes, higher loan growth better capital markets, and financial deregulation. Schorr expects Trust Banks to have ongoing fee compression in core custody, lower NIR rate leverage, and increased competition. Schorr maintained his $48.50 price target on BNY Mellon shares.
01/20/17
01/20/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Bristol-Myers (BMY) downgraded to Market Perform from Outperform at Cowen with analyst Steve citing the company's announcement that it is not pursuing an early regulatory filing of the Opdivo plus Yervoy combination in first-line treatment of non-small cell lung cancer. He cut his price target on Bristol shares to $65 from $85. 2. BNY Mellon (BK) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Brian Kleinhanzl citing lower expectations after the company's fourth quarter results missed his estimates. The analyst lowered his price target for the shares to $48 from $54. 3. Western Union (WU) downgraded to Sell from Neutral at Compass Point. 4. Teva (TEVA) downgraded to Neutral from Overweight at JPMorgan with analyst Chris Schott saying the generic operating environment remains challenging. 5. CSX (CSX) downgraded to Hold from Buy at Deutsche Bank with analyst Amit Mehrotra citing valuation following yesterday's 23% rally. The stock is within 5% of the analyst's "Blue Sky" scenario and above his unchanged price target of $42. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CVS

CVS Health

$78.54

-0.79 (-1.00%)

, AET

Aetna

$207.68

-1.49 (-0.71%)

06:21
11/20/18
11/20
06:21
11/20/18
06:21
Hot Stocks
CVS Health, Aetna deal expected to close after Thanksgiving holiday »

In connection with the…

CVS

CVS Health

$78.54

-0.79 (-1.00%)

AET

Aetna

$207.68

-1.49 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIEN

Ciena

$32.46

-1.22 (-3.62%)

06:21
11/20/18
11/20
06:21
11/20/18
06:21
Downgrade
Ciena rating change  »

Ciena downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACHC

Acadia

$32.05

-0.51 (-1.57%)

, KKR

KKR

$21.08

-0.75 (-3.44%)

06:20
11/20/18
11/20
06:20
11/20/18
06:20
Periodicals
Correction: KKR still in talks to acquire Acadia Healthcare, NY Post reports »

The New York Post…

ACHC

Acadia

$32.05

-0.51 (-1.57%)

KKR

KKR

$21.08

-0.75 (-3.44%)

ACAD

Acadia

$18.14

-0.78 (-4.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSDT

Helius Medical

06:19
11/20/18
11/20
06:19
11/20/18
06:19
Upgrade
Helius Medical rating change  »

Helius Medical upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QLYS

Qualys

$69.24

-5.355 (-7.18%)

06:19
11/20/18
11/20
06:19
11/20/18
06:19
Upgrade
Qualys rating change  »

Qualys upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 09

    Jan

NERV

Minerva

$8.32

-0.09 (-1.07%)

06:17
11/20/18
11/20
06:17
11/20/18
06:17
Conference/Events
Minerva management to host key opinion leader breakfast meeting »

Management hosts a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

INGN

Inogen

$137.57

-4.28 (-3.02%)

06:16
11/20/18
11/20
06:16
11/20/18
06:16
Upgrade
Inogen rating change  »

Inogen upgraded to Strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 04

    Dec

PSTG

Pure Storage

$17.56

-1.56 (-8.16%)

06:15
11/20/18
11/20
06:15
11/20/18
06:15
Recommendations
Pure Storage analyst commentary  »

Pure Storage price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

COWN

Cowen Group

$14.67

-0.38 (-2.52%)

06:14
11/20/18
11/20
06:14
11/20/18
06:14
Conference/Events
Cowen Group to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

GOOG

Alphabet

$1,019.00

-43.01 (-4.05%)

, GOOGL

Alphabet Class A

$1,026.23

-42.9 (-4.01%)

06:13
11/20/18
11/20
06:13
11/20/18
06:13
Periodicals
Google to invest $690M to build new data center in Denmark, Reuters reports »

Google will invest $690M…

GOOG

Alphabet

$1,019.00

-43.01 (-4.05%)

GOOGL

Alphabet Class A

$1,026.23

-42.9 (-4.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 03

    Mar

KEG

Key Energy

$8.25

0.02 (0.24%)

06:10
11/20/18
11/20
06:10
11/20/18
06:10
Downgrade
Key Energy rating change  »

Key Energy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$91.34

-1.95 (-2.09%)

06:09
11/20/18
11/20
06:09
11/20/18
06:09
Hot Stocks
Lowe's sees 'positive trends' in FY19 »

Lowe's CEO Marvin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

STXB

Spirit of Texas Bancshares

$19.23

-0.66 (-3.32%)

06:08
11/20/18
11/20
06:08
11/20/18
06:08
Initiation
Spirit of Texas Bancshares initiated  »

Spirit of Texas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$91.34

-1.95 (-2.09%)

06:07
11/20/18
11/20
06:07
11/20/18
06:07
Hot Stocks
Lowe's to exit Mexico retail operations, exploring strategic alternatives »

Management has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

STKS

One Group Hospitality

$2.77

-0.18 (-6.10%)

06:06
11/20/18
11/20
06:06
11/20/18
06:06
Initiation
One Group Hospitality initiated  »

One Group Hospitality…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

LOW

Lowe's

$91.34

-1.95 (-2.09%)

06:04
11/20/18
11/20
06:04
11/20/18
06:04
Earnings
Lowe's sees FY18 adj. EPS $5.08-$5.13, consensus $5.15 »

Sees FY18 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CDNS

Cadence Design

$42.78

-2.98 (-6.51%)

, SNPS

Synopsys

$85.72

-4.37 (-4.85%)

06:04
11/20/18
11/20
06:04
11/20/18
06:04
Initiation
Cadence Design, Synopsys initiated  »

Cadence Design initiated…

CDNS

Cadence Design

$42.78

-2.98 (-6.51%)

SNPS

Synopsys

$85.72

-4.37 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 05

    Dec

  • 13

    Dec

  • 12

    Mar

KW

Kennedy Wilson

$18.63

-0.2 (-1.06%)

06:03
11/20/18
11/20
06:03
11/20/18
06:03
Hot Stocks
Kennedy Wilson signs two lease deals in Europe with WeWork and ASOS »

Kennedy Wilson has signed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$91.34

-1.95 (-2.09%)

06:02
11/20/18
11/20
06:02
11/20/18
06:02
Earnings
Lowe's reports Q3 adj. EPS $1.04, consensus 98c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

SNPS

Synopsys

$85.72

-4.37 (-4.85%)

06:02
11/20/18
11/20
06:02
11/20/18
06:02
Initiation
Synopsys initiated  »

Synopsys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 13

    Dec

CYAD

Celyad

$26.97

(0.00%)

06:00
11/20/18
11/20
06:00
11/20/18
06:00
Conference/Events
Celyad management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 22

    Nov

  • 27

    Nov

  • 01

    Dec

  • 03

    Dec

  • 10

    Dec

CSII

Cardiovascular Systems

$28.79

-1.7 (-5.58%)

05:59
11/20/18
11/20
05:59
11/20/18
05:59
Conference/Events
Cardiovascular Systems management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

MDGL

Madrigal Pharmaceuticals

$120.49

-8.98 (-6.94%)

05:57
11/20/18
11/20
05:57
11/20/18
05:57
Conference/Events
Madrigal Pharmaceuticals management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

MCD

McDonald's

$186.69

-0.96 (-0.51%)

05:54
11/20/18
11/20
05:54
11/20/18
05:54
Conference/Events
McDonald's management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

KEX

Kirby

$74.67

-1.225 (-1.61%)

05:51
11/20/18
11/20
05:51
11/20/18
05:51
Conference/Events
Kirby management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.